These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11351477)

  • 21. Activity of dalbavancin tested against Staphylococcus spp. and beta-hemolytic Streptococcus spp. isolated from 52 geographically diverse medical centers in the United States.
    Biedenbach DJ; Ross JE; Fritsche TR; Sader HS; Jones RN
    J Clin Microbiol; 2007 Mar; 45(3):998-1004. PubMed ID: 17215346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intra- and Interinstitutional Evaluation of an Etest for Vancomycin Minimum Inhibitory Concentration Measurement in Staphylococcus aureus Blood Isolates.
    Falcón R; Madrid S; Tormo N; Casañ C; Albert E; Gimeno C; Navarro D
    Clin Infect Dis; 2015 Nov; 61(9):1490-2. PubMed ID: 26187018
    [No Abstract]   [Full Text] [Related]  

  • 23. [Sensitivity of 207 Staphylococcus aureus strains to penicillin G, Penicillin V, methicillin, cloxacillin and oxacillin].
    Pino M; Pinto E; Guajardo M
    Pediatria (Santiago); 1965; 8(2):105-12. PubMed ID: 5174422
    [No Abstract]   [Full Text] [Related]  

  • 24. [Penicillinase resistant semisynthetic penicillins--antibacterial action and circulatory characteristics of patients' blood].
    Fomina IP; Kuznetsova SM; Vasil'ev VK; Bodunkova LE
    Antibiotiki; 1971 Feb; 16(2):153-8. PubMed ID: 5208228
    [No Abstract]   [Full Text] [Related]  

  • 25. Vancomycin-resistant Staphylococcus aureus in the clinic: not quite armageddon.
    Bush K
    Clin Infect Dis; 2004 Apr; 38(8):1056-7. PubMed ID: 15095206
    [No Abstract]   [Full Text] [Related]  

  • 26. Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates.
    Hussain FM; Boyle-Vavra S; Shete PB; Daum RS
    J Infect Dis; 2002 Sep; 186(5):661-7. PubMed ID: 12195353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The activity of daptomycin against wild-type Staphylococcus aureus and strains with reduced susceptibility to vancomycin.
    Sader HS; Jones RN
    Clin Infect Dis; 2006 Sep; 43(6):798-9; author reply 799-800. PubMed ID: 16912964
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.
    Charles PG; Ward PB; Johnson PD; Howden BP; Grayson ML
    Clin Infect Dis; 2004 Feb; 38(3):448-51. PubMed ID: 14727222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Etest synergy testing of clinical isolates of Staphylococcus aureus demonstrating heterogeneous resistance to vancomycin.
    Tsuji BT; Rybak MJ
    Diagn Microbiol Infect Dis; 2006 Jan; 54(1):73-7. PubMed ID: 16368477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time-kill studies with oxacillin, vancomycin, and teicoplanin versus Staphylococcus aureus.
    Greenberg RN; Benes CA
    J Infect Dis; 1990 May; 161(5):1036-7. PubMed ID: 2139086
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibiotic-tolerant Staphylococcus aureus.
    Watanakunakorn C
    J Antimicrob Chemother; 1978 Nov; 4(6):561-8. PubMed ID: 251180
    [No Abstract]   [Full Text] [Related]  

  • 32. Nosocomial methicillin--resistant Staphylococcus aureus with reduced susceptibility to vancomycin.
    Bhat G; Kamath S; Hussain A
    Indian J Pathol Microbiol; 2006 Apr; 49(2):311-2. PubMed ID: 16933753
    [No Abstract]   [Full Text] [Related]  

  • 33. [Formation of protoplasts from strains of Staphylococcus aureus and Escherichia coli under the action of polysynthetic penicillins].
    Moroz AF; Vaĭntraub EA
    Antibiotiki; 1968 Jun; 13(6):519-24. PubMed ID: 4878099
    [No Abstract]   [Full Text] [Related]  

  • 34. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus.
    Patel JB; Jevitt LA; Hageman J; McDonald LC; Tenover FC
    Clin Infect Dis; 2006 Jun; 42(11):1652-3. PubMed ID: 16652325
    [No Abstract]   [Full Text] [Related]  

  • 36. Reply to Kaasch et al.
    Cervera C; Garcia de la Maria C; Pericas JM; Moreno A; Miro JM
    Clin Infect Dis; 2015 Feb; 60(4):669-70. PubMed ID: 25371491
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Barcia-Macay M; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2006 Dec; 58(6):1177-84. PubMed ID: 17062609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence of a USA300 vancomycin-intermediate Staphylococcus aureus.
    Hageman JC; Patel J; Franklin P; Miscavish K; McDougal L; Lonsway D; Khan FN
    Diagn Microbiol Infect Dis; 2008 Dec; 62(4):440-2. PubMed ID: 18842378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The need for accuracy in performing vancomycin intermediate resistant Staphylococcus aureus (VISA) and hetero--VISA detection methods.
    Wootton M
    Int J Antimicrob Agents; 2006 Dec; 28(6):586. PubMed ID: 17049817
    [No Abstract]   [Full Text] [Related]  

  • 40. Heterogeneous vancomycin-resistant Staphylococcus aureus (hetero-VISA) in Singapore.
    Sng LH; Koh TH; Wang GC; Hsu LY; Kapi M; Hiramatsu K
    Int J Antimicrob Agents; 2005 Feb; 25(2):177-9. PubMed ID: 15664490
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.